1. Home
  2. ARTL vs EDBL Comparison

ARTL vs EDBL Comparison

Compare ARTL & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • EDBL
  • Stock Information
  • Founded
  • ARTL 2011
  • EDBL 2020
  • Country
  • ARTL United States
  • EDBL United States
  • Employees
  • ARTL N/A
  • EDBL N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • ARTL Health Care
  • EDBL Consumer Staples
  • Exchange
  • ARTL Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • ARTL 3.3M
  • EDBL 2.7M
  • IPO Year
  • ARTL N/A
  • EDBL 2022
  • Fundamental
  • Price
  • ARTL $1.02
  • EDBL $2.25
  • Analyst Decision
  • ARTL
  • EDBL
  • Analyst Count
  • ARTL 0
  • EDBL 0
  • Target Price
  • ARTL N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • ARTL 1.2M
  • EDBL 70.0K
  • Earning Date
  • ARTL 05-16-2025
  • EDBL 05-15-2025
  • Dividend Yield
  • ARTL N/A
  • EDBL N/A
  • EPS Growth
  • ARTL N/A
  • EDBL N/A
  • EPS
  • ARTL N/A
  • EDBL N/A
  • Revenue
  • ARTL N/A
  • EDBL $13,857,000.00
  • Revenue This Year
  • ARTL N/A
  • EDBL $29.56
  • Revenue Next Year
  • ARTL N/A
  • EDBL $20.00
  • P/E Ratio
  • ARTL N/A
  • EDBL N/A
  • Revenue Growth
  • ARTL N/A
  • EDBL N/A
  • 52 Week Low
  • ARTL $0.82
  • EDBL $1.82
  • 52 Week High
  • ARTL $1.59
  • EDBL $230.00
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 52.13
  • EDBL 49.19
  • Support Level
  • ARTL $0.99
  • EDBL $1.87
  • Resistance Level
  • ARTL $1.05
  • EDBL $2.40
  • Average True Range (ATR)
  • ARTL 0.07
  • EDBL 0.14
  • MACD
  • ARTL 0.00
  • EDBL 0.09
  • Stochastic Oscillator
  • ARTL 30.00
  • EDBL 61.51

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: